The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II study comparing cabazitaxel/prednisone to cabazitaxel alone for second-line chemotherapy in men with metastatic castrate resistant prostate cancer (mCRPC): CABACARE.
 
Carlo Buonerba
Research Funding - Astellas Pharma (Inst); Quercegen Pharmaceuticals (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag; Sanofi
 
Davide Bosso
Travel, Accommodations, Expenses - Sanofi
 
Sabino De Placido
No Relationships to Disclose
 
Giuseppe di Lorenzo
Honoraria - Ipsen; Sanofi/Aventis
Consulting or Advisory Role - Ipsen; Sanofi
Research Funding - Astellas Pharma (Inst); Quercegen Pharmaceuticals (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Sanofi/Aventis